Home / 510(k) Clearances / K220988

510(k) K220988

EksoNR by Ekso Bionics, Inc. — Product Code PHL

K220988 is an FDA 510(k) premarket notification submitted by Ekso Bionics, Inc. for the device "EksoNR". The FDA issued a decision of Substantially Equivalent on June 9, 2022. The device falls under product code PHL (Powered Exoskeleton), a Class II device regulated under 21 CFR 890.3480. Ekso Bionics, Inc. has at least 3 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
June 9, 2022
Date Received
April 4, 2022
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Powered Exoskeleton
Device Class
Class II
Regulation Number
890.3480
Review Panel
NE
Submission Type

A powered exoskeleton is a prescription device that is composed of an external, powered, motorized orthosis that is placed over a person's paralyzed or weakened lower extremity limb(s) for medical purposes.

Other clearances by Ekso Bionics, Inc.

  • K200574 — EksoNR (June 19, 2020)
  • K161443 — Ekso™ (version 1.1) and Ekso GT™ (version 1.2) (July 19, 2016)
  • K143690 — Ekso™ (version 1.1) and Ekso GT™ (version 1.2) (April 1, 2016)

Other clearances for product code PHL

  • K250904 — Atalante X (October 24, 2025)
  • K241822 — ReWalk® 7 Personal Exoskeleton (50-20-0005) (March 12, 2025)
  • K233695 — Medical HAL Lower Limb Type (HAL-ML) (May 7, 2024)
  • K232077 — Atalante X (December 13, 2023)
  • K221696 — ReWalk P6.0 (March 2, 2023)
  • K221859 — Atalante (December 29, 2022)
  • K213452 — GEMS-H (April 21, 2022)
  • K201473 — ExoAtlet-II (July 16, 2021)
  • K201559 — HAL for Medical Use(Lower Limb type) (October 2, 2020)
  • K201539 — Keeogo Dermoskeleton System (September 9, 2020)

FDA data resources